Status:
RECRUITING
Transgender In Transition
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Gender Incongruence
Eligibility:
All Genders
18+ years
Brief Summary
Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.
Detailed Description
Gender-affirming hormone treatment impacts myriads of body functions, from which it has to be assumed that only a minority has already been elucidated so far. This project aims to investigate the cons...
Eligibility Criteria
Inclusion
- diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
- written informed consent following adequate oral and written Information
- before gender-affirming hormonal treatment
Exclusion
- pregnancy or breast-feeding
Key Trial Info
Start Date :
May 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2034
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT04028219
Start Date
May 15 2019
End Date
May 15 2034
Last Update
November 8 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, Germany, 60590
2
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
3
Medical Center of the Ludwig-Maximilians-University of Munich
Munich, Germany
4
Universitätsspital Basel
Basel, Switzerland, 4031